Vedolizumab In Crohn’s Disease; A Budget Impact Model for A Novel Drug In A Recession Environment
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2186
https://www.valueinhealthjournal.com/article/S1098-3015(15)04262-X/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1600
First Page :
A623
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04262-X&doi=10.1016/j.jval.2015.09.2186